Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in XENON PHARMACEUTICALS INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 236 shares of XENE (XENON PHARMACEUTICALS INC), worth $10,578 as of 2025-Q4. This is a new position.
Current Value
$10,578
Current Shares
236
Total Value Change
-$6.3M
Total Shares Change
-162,230
Other major holders of XENE: FMR LLC
New |
| 236 |
- |
| $10,578 |
| 0.0% |
| $44.12 |
26 |
| 2025-Q3 | Exited | 0 | -100.0% | $0 | 0.0% | $39.06 | 0 |
| 2025-Q2 | Increased | 404,384 | +536.1% | $12.7M | 0.0% | $32.40 | 45 |
| 2025-Q1 | Decreased | 63,568 | -66.9% | $2.1M | 0.0% | $34.26 | 0 |
| 2024-Q4 | Increased | 191,852 | +17.9% | $7.5M | 0.0% | $38.53 | 32 |
| 2024-Q3 | Increased | 162,683 | +0.1% | $6.4M | 0.0% | $38.65 | 27 |
| 2024-Q2 | Increased | 162,466 | +109.7% | $6.3M | 0.0% | $38.99 | 44 |